<SEC-DOCUMENT>0001558370-20-007075.txt : 20200528
<SEC-HEADER>0001558370-20-007075.hdr.sgml : 20200528
<ACCEPTANCE-DATETIME>20200528154151
ACCESSION NUMBER:		0001558370-20-007075
CONFORMED SUBMISSION TYPE:	SD
PUBLIC DOCUMENT COUNT:		3
<RULE>
<RULE-NAME>13p-1
<ITEM>
<ITEM-NUMBER>1.01
<ITEM-PERIOD>20191231
</ITEM>
</RULE>
FILED AS OF DATE:		20200528
DATE AS OF CHANGE:		20200528

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SD
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		20920874

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>SD
<SEQUENCE>1
<FILENAME>mmsi-20200528xsd.htm
<DESCRIPTION>SD
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.6.0.116-->
<!--Created on: 5/28/2020 1:41:40 PM-->
<html>
	<head>
		<title>
			mmsi_current Folio_SD
		</title>
	</head>
	<body><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 83.98%;">
			<tr>
				<td valign="bottom" style="width:393.05pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:1.00pt">
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;"><img src="mmsi-20200528xsdg001.jpg" style="width: 3.884722in; height: 0.6972222in" alt="Picture 1"></font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:393.05pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;">UNITED STATES </font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION </font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-family:inherit;">Washington, D.C. 20549 </font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;">FORM SD </font></p>
					<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;">Specialized Disclosure Report </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 8pt;line-height:120%;text-align:center;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;"><img src="mmsi-20200528xsdg001.jpg" style="width: 3.884722in; height: 0.6972222in" alt="Picture 3"></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 83.98%;">
			<tr>
				<td valign="middle" style="width:393.05pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:393.05pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 18pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;font-size:18pt;">MERIT MEDICAL SYSTEMS, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:393.05pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(Exact name of the registrant as specified in its charter)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:120%;font-family:Calibri;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:120%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 91.20%;">
			<tr>
				<td valign="middle" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:36.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:32.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:36.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:32.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:32.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">Utah</font></p>
				</td>
				<td valign="bottom" style="width:36.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">0-18592</font></p>
				</td>
				<td valign="bottom" style="width:32.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">87-0447695</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:32.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation)</font></p>
				</td>
				<td valign="bottom" style="width:36.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(Commission File Number)</font></p>
				</td>
				<td valign="bottom" style="width:32.00%;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(IRS Employer Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:120%;font-family:Calibri;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 83.00%;">
			<tr>
				<td valign="middle" style="width:50.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:48.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="middle" style="width:388.45pt;padding:0pt;">
					<p style="margin:0pt;line-height:120%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:50.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:48.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:194.25pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">1600 West Merit Parkway, South Jordan, Utah</font></p>
				</td>
				<td valign="bottom" style="width:07.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:186.45pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">84095</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:194.25pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></p>
				</td>
				<td valign="bottom" style="width:07.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:186.45pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(Zip code)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:120%;font-family:Calibri;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:120%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 91.40%;">
			<tr>
				<td colspan="3" valign="middle" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:120%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:44.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:auto;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">Brian G. Lloyd</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(801) 253-1600</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="middle" style="width:auto;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">(Name and telephone number, including area code, of the person to contact in connection with this report.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 8pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-size:10pt;">Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies: </font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-size:10pt;text-decoration:underline;">&#x221A;</font><font style="display:inline;font-family:inherit;font-size:10pt;"> Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019&nbsp;</font><font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">Section 1 - Conflict Minerals Disclosure</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">Item 1.01 Conflict Minerals Disclosure and Report </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-size:10pt;">In accordance with Rule 13p-1 under the Securities Exchange Act of 1934, Merit Medical Systems, Inc. (the "Company") is filing a Conflict Minerals Report for the calendar year 2019. A copy of the report is filed as Exhibit 1.01 hereto and is publicly available at <a href="#sC539FAD71B807AD71A790E6FF34A08EB">https://www.merit.com/about/conflict-minerals-report.</a> The content of any website referred to in this Form SD, including any exhibit hereto, is included for general information only and is not incorporated by reference in this Form SD.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">Item 1.02 Exhibit </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-size:10pt;">The Company&#x2019;s Conflict Minerals Report for the calendar year ended December 31, 2019 is filed as Exhibit 1.01 to this Form SD.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">Section 2 - Exhibit </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">Item 2.01 Exhibit</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<a href="mmsi-20200528xex1d01.htm"><font style="display:inline;font-family:inherit;font-size:10pt;">Exhibit 1.01 - Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.</font></a>&nbsp;
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 91.40%;">
			<tr>
				<td valign="middle" style="width:427.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<a name="s006773A4BD0AB00574170E6FF39DCFF1"></a><font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:427.75pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:100.00%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:427.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-weight:bold;font-size:10pt;">SIGNATURE</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned. 20</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 96.48%;">
			<tr>
				<td valign="middle" style="width:52.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:04.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:44.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="middle" style="width:451.55pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:52.00%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:04.00%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:44.00%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:234.80pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">Dated: May 28, 2020</font></p>
				</td>
				<td colspan="2" valign="top" style="width:216.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">MERIT MEDICAL SYSTEMS,&nbsp;INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:234.80pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:216.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:234.80pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:216.75pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:234.80pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 1pt;">
						<font style="display:inline;font-family:inherit;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:18.05pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">By:</font></p>
				</td>
				<td valign="bottom" style="width:198.70pt;border-bottom:1pt solid #000000 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">/s/ Brian G. Lloyd</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:234.80pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 1pt;">
						<font style="display:inline;font-family:inherit;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:18.05pt;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 1pt;">
						<font style="display:inline;font-family:inherit;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:198.70pt;border-top:1pt solid #000000 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt;">
						<font style="display:inline;font-family:inherit;font-size:10pt;">Chief Legal Officer and Corporate Secretary</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.01
<SEQUENCE>2
<FILENAME>mmsi-20200528xex1d01.htm
<DESCRIPTION>EX-1.01
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.6.0.116-->
<!--Created on: 5/28/2020 1:41:40 PM-->
<html>
	<head>
		<title>
			Exhibit 1.01
		</title>
	</head>
	<body><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">CONFLICT MINERALS REPORT</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">MERIT MEDICAL SYSTEMS, INC.<br>YEAR ENDED DECEMBER 31, 2019</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">This Conflict Minerals Report (this &#x201C;</font><font style="display:inline;font-weight:bold;">Report</font><font style="display:inline;">&#x201D;) for the year ended December 31, 2019 is presented by Merit Medical Systems, Inc.&nbsp;&nbsp;(&#x201C;</font><font style="display:inline;font-weight:bold;">Merit</font><font style="display:inline;">&#x201D;) to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the &#x201C;</font><font style="display:inline;font-weight:bold;">Rule</font><font style="display:inline;">&#x201D;).&nbsp;&nbsp;The Rule was adopted by the Securities and Exchange Commission (&#x201C;</font><font style="display:inline;font-weight:bold;">SEC</font><font style="display:inline;">&#x201D;) to implement reporting and disclosure requirements related to conflict minerals as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.&nbsp;&nbsp;The Rule imposes certain reporting obligations on SEC registrants whose manufactured products contain conflict minerals which are necessary to the functionality or production of their products.&nbsp;&nbsp;Conflict minerals are defined as cassiterite, columbite-tantalite, gold, wolframite, and their derivatives, which are limited to tin, tantalum, tungsten, and gold (&#x201C;</font><font style="display:inline;font-weight:bold;">3TG</font><font style="display:inline;">&#x201D;).</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Company Overview</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care and endoscopy. Merit&#x2019;s mission is to be the most customer-focused company in healthcare. Merit designs, develops, manufactures and markets innovative medical products that offer a high level of quality, value and safety to its customers, as well as the patients they serve. </font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit&#x2019;s products are used in the following clinical areas: diagnostic and interventional cardiology; interventional radiology; neurointerventional radiology; vascular, general and thoracic surgery; electrophysiology; cardiac rhythm management; interventional pulmonology; interventional nephrology; orthopaedic spine surgery; interventional oncology; breast cancer surgery; pain management; outpatient access centers; intensive care; computed tomography; ultrasound; and interventional gastroenterology.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit maintains a diverse, multi-campus manufacturing footprint in North America, Europe, and Asia with a true global distribution network focused on delivering our products and technologies to our customers.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Due DILIGENCE</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit determined that some of its products were likely to contain 3TG due to the anticipated presence of such minerals in certain products manufactured by or for Merit or in parts or materials obtained from suppliers.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit has conducted a good faith and reasonable country of origin inquiry regarding the origin of the 3TG necessary for the functionality or production of products manufactured, or contracted to be manufactured, by or for Merit.&nbsp;&nbsp;The reasonable country of origin inquiry consisted of a survey of supply-chain suppliers of parts or materials necessary for the functionality or production of products manufactured by or for Merit.&nbsp;&nbsp;As a purchaser, Merit is several steps removed in the supply chain from the actual mining of and processing of minerals that are in the purchased materials used for its products. Given the complexity of its supply chain, Merit relies on its suppliers to provide information relevant to the origin of the 3TG contained in purchased materials supplied to it, including sources of 3TG that are supplied to them in earlier stages of the supply chain. A large number of Merit&#x2019;s suppliers and their suppliers are not subject to Securities and Exchange Commission (&#x201C;SEC&#x201D;) regulations; therefore, its ability to obtain information responsive to the Rule&#x2019;s requirements is subject to the cooperation of these suppliers.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit utilized the </font><font style="display:inline;text-transform:uppercase;">Organisation for Economic Co-operation and Development Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas</font><font style="display:inline;">, to the extent practicable and reasonable given Merit&#x2019;s particular supply chain and industry.&nbsp;&nbsp;Merit sought to identify the originating smelter or refinery for 3TG in an attempt to discover whether or not the smelter or refinery had been determined to be conflict-free by existing industry and/or trade association programs.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">For the 2019 reporting year, Merit surveyed its suppliers with an 83% response rate. Merit did additional work in the past year to narrow its &#x201C;in scope&#x201D; number of suppliers subject to the survey, and expects its greater scrutiny of the supply chain will result in improved response rates and more meaningful diligence in the years to come.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Results</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Of the suppliers that responded to Merit&#x2019;s survey questionnaire, the vast majority responded that their products, parts, or processes either did not contain 3TG or that any 3TG contained in their products, parts, or processes did not originate in the Democratic Republic of the Congo or adjoining countries.&nbsp;&nbsp;A significant majority of Merit&#x2019;s suppliers that reported the presence of 3TG identified the smelter facilities providing such minerals as being &#x201C;conflict free,&#x201D; as determined by programs such as the Conflict Free Smelter Program of the Electronic Industry Citizenship Coalition and the Global e-Sustainability Initiative or that the supply of 3TG originated from scrap or recycled sources.&nbsp;&nbsp;A small number of suppliers responded that their smelters confirmed sourcing from the Democratic Republic of the Congo </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;"><font style="display:inline;">or adjoining countries, but these suppliers were unable to confirm that the smelters were conflict-free.&nbsp;&nbsp;Because not all of Merit&#x2019;s suppliers adequately responded to Merit&#x2019;s multiple inquiries, Merit has been unable to determine the precise origin of some of the 3TG minerals contained in or utilized in the manufacture of such products for the year ended December 31, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Based on Merit&#x2019;s due diligence efforts, Merit does not have sufficient information to conclusively determine all of the smelters or the countries of origin for the 3TG minerals in all of Merit&#x2019;s products.&nbsp; </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Independent Audit</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">This Report has not been subject to an independent private sector audit, in recognition of the final judgment by the District Court for the District of Columbia in National Association of Manufacturers, et. al. v. Securities and Exchange Commission, et. al., No. 13-CF-000635 (D.D.C. Apr. 3, 2017), and regulatory guidance provided by the SEC on remand.&nbsp;Moreover, pursuant to the SEC rule and SEC staff guidance, because Merit does not affirmatively label its products as &#x201C;DRC conflict free,&#x201D; it is not required to obtain an independent private-sector audit (IPSA) and include the audit report as part of a conflict minerals report.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Policies Applicable to Conflict minerals</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">As part of its due diligence efforts, Merit also has developed a Conflict Minerals Policy (available at </font><font style="display:inline;text-decoration:underline;">http://www.merit.com/about/conflict-minerals-policy/</font><font style="display:inline;">) and a Code of Conduct for Suppliers (available at </font><font style="display:inline;text-decoration:underline;">http://www.merit.com/about/code-of-conduct-for-suppliers/</font><font style="display:inline;">). The Code of Conduct for Suppliers was recently updated to include important expectations in the area of Corporate Social Responsibility (CSR), particularly labor standards. These two documents outline the expectations Merit has for its suppliers, as well as steps Merit may choose to take for any non-compliance by its suppliers with the Policy or Code of Conduct.&nbsp; </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;text-transform:uppercase;">Steps to be Taken in 2020</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:150%;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;">Merit plans to continue to improve its due diligence process in 2020 to further mitigate the risk that the necessary 3TG in Merit&#x2019;s products does not finance or benefit armed groups in the Democratic Republic of the Congo or adjoining countries.&nbsp;&nbsp;These improvements include:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="line-height:150%;font-family:Calibri;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt 0pt 8pt;font-family:Symbol;line-height:150%;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:150%;font-family:Calibri;font-size: 11pt;margin:0pt;">
			<font style="display:inline;color:#000000;">Continuing to strengthen engagement with relevant suppliers, including modifying its due diligence system and supplier database to ensure that its communications are focused on those suppliers most likely to provide Merit with the subject 3TG metals in question.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="line-height:150%;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt 0pt 8pt;font-family:Symbol;line-height:150%;border-bottom:1pt none #D9D9D9;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:150%;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
			<font style="display:inline;color:#000000;">Hiring and assigning additional resources in its Corporate Social Responsibility (CSR) program, which should benefit its due diligence under both the US conflict minerals regulation as well as prepare for European Union conflict minerals requirements that go into effect January 1, 2021.</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt 0pt 8pt;font-family:Symbol;line-height:150%;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
			<font style="display:inline;color:#000000;">Adopting new systems and technologies to enhance Merit&#x2019;s scrutiny of its supply chain, including the assignment of resources from Merit&#x2019;s Procurement and Operations teams to improve the vetting and monitoring of Merit&#x2019;s suppliers.</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt 0pt 8pt;font-family:Symbol;line-height:150%;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
			<font style="display:inline;color:#000000;">Adapting to new and different supplier due diligence and sourcing strategies in the wake of the COVID-19 pandemic.</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt 0pt 8pt;font-family:Symbol;line-height:150%;border-top:1pt none #D9D9D9;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:150%;border-top:1pt none #D9D9D9 ;font-family:Calibri;font-size: 11pt;margin:0pt;">
			<font style="display:inline;color:#000000;">Continuing to provide feedback to suppliers regarding inadequate reporting or completion of the CMRT assessment.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mmsi-20200528xsdg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20200528xsdg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M!8A;H>C2[,%_^ @X'U/I76T0CW%B:R22@]6DV_.RT_5^;\BM_9UE_P ^=O\
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M;EIWN73!_P!E5("CVJ[6=DKLYG-RBI3ERQZ)?Y77WMW?F2ZAX/TV3?=Z:O\
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M=I/?WL%G:IOGG<1QK[G^E7B)W?(CFR/"J,7B9^B_5C3;RBU6Y*$0NYC5^Q8
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M:?%'_7Q!_P"B5HNO^2C:;_V#9_\ T..K^C:#!HK73QW5W<RW3J\LEU('8D#
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MCAS?'4*U!0IRN[C=?T"R\2:6UC?*VS<'1T.&1AT(K$\,?#W3/#5\;Y9YKNZ
M*QO* !&#UP!W]ZZ^BNEPBWS-:GA1Q5:%-THR]U]#%\2^&;+Q1IPM+PNC(V^*
M6/[R-_4>U9?A7X?Z?X8NVO1<27=V5*))(H4(#UP!W/K7744.$6^:VHXXJM&D
MZ*E[KZ&'XG\+6/BJP2WNV>.2)MT4T?WD)Z]>H/I7&?\ "FK?_H.3_P#@.O\
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
